Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowWhole-Body IrradiationBone Marrow CellsLeukemiaTransplantation ConditioningAnemia, AplasticTransplantation, AutologousTransplantation ChimeraBusulfanTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoietic Stem Cell TransplantationGraft SurvivalHistocompatibility TestingLeukocyte TransfusionGraft vs Tumor EffectRecurrenceHistocompatibilityHematologic NeoplasmsLeukemia, Myeloid, AcuteRadiation ChimeraPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host ReactionCyclophosphamideGraft vs Leukemia EffectLymphocyte DepletionRemission InductionTransplantation, IsogeneicAcute DiseaseBone and BonesHepatic Veno-Occlusive DiseaseLymphocyte TransfusionLeukemia, MyeloidImmunosuppressive AgentsBone Marrow PurgingCombined Modality TherapyMice, Inbred C57BLHematopoietic Stem CellsImmunosuppressionChimeraT-LymphocytesMyelodysplastic SyndromesTreatment OutcomeTime FactorsNuclear FamilyHematopoiesisLiver TransplantationTransplantation ImmunologyCyclosporineGraft RejectionSurvival AnalysisActuarial AnalysisHLA AntigensCytomegalovirus InfectionsRetrospective StudiesHematologic DiseasesFatal OutcomeLymphoma, Non-HodgkinMice, Inbred BALB CSevere Combined ImmunodeficiencyCytarabineSurvival RateBone Marrow DiseasesKidney TransplantationAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesDisease-Free SurvivalPancytopeniaSpleenLeukocyte CountGranulocyte Colony-Stimulating FactorLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsStem Cell TransplantationInfectionMethotrexateBone Marrow ExaminationLymphomaEtoposideNeoplasm, ResidualAntilymphocyte SerumImmunocompromised HostGanciclovirMultiple MyelomaCyclosporinsFlow CytometryPrognosisBone RemodelingImmunophenotypingMinor Histocompatibility AntigensColony-Forming Units AssayMice, Inbred AKRCytogeneticsPneumonia, ViralBone Marrow NeoplasmsMice, Inbred C3HThymus Gland